Neumirna Therapeutics
RNA Therapeutics Neurological Epilepsy Pain ASO Antisense Oligonucleotides mirna.
Enterprise value
$88—132m
Company register number
| Date | Investors | Amount | Round |
|---|---|---|---|
* | €20.0m | Series A | |
| Total Funding | 000k | ||
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads